Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) with cyclooxygenase (COX) inhibitory activity are commonly used in various inflammatory diseases. In this study, to examine the immunomodulatory effects of well known NSAIDs at clinically available doses, macrophage- and T cell-mediated immune responses such as tumor necrosis factor (TNF)-a release and nitric oxide (NO) production, cell-cell adhesion, phagocytic uptake and lymphocyte proliferation were investigated. NSAIDs tested significantly enhanced TNF-α release from lipopolysaccharide (LPS)-activated RAW264.7 cells at certain concentrations (fenoprofen, indomethacine, piroxicam, ace-dofenac, diclofenac and sulindac) or in a dose-dependent manner (aspirin and phenyibuta-zone). Of NSAIDs, phenylbutazone and aspirin most potently attenuated NO production, although sulindac was the only compound with cytoprotective activity against LPS-induced cytotoxicity. Most NSAIDs used displayed weak or no modulatory effects on phagocytic uptake and CD29- or CD43-mediated cell-cell adhesion. Interestingly, however, phenylbutazone itself triggered cell-cell clustering under normal culture conditions and enhanced the phagocytic activity. Aspirin and phenylbutazone also dose-dependently attenuated CD4+ T cell proliferation stimulated by concanavalin A (Con A) and CD8+ CTLL-2 cell proliferation induced by interleukin (IL)-2. Sulindac only blocked CTLL-2 cell proliferation. These results suggest that NSAIDs may differentially exert immunomodulatory effects on activated macrophages and lymphocytes, and some of the effects may enforce NSAID’s therapeutic effect against inflammatory symptoms.
Similar content being viewed by others
References
Ashkar, A. A. and Rosenthal, K. L., Toll-like receptor 9, CpG DNA and innate immunity.Curr. Mol. Med., 2, 545–256 (2002).
Berenguer, B., Alarcon De La Lastra, C., Motilva, V., La Casa, C., Herrerias, J. M., Pozo, D., and Calero, M. J., Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam.Dig. Dis. Sci., 49, 937–947 (2004).
Berg, J., Fellier, H., Christoph, T., Grarup, J., and Stimmeder, D., The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, ir.ducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro.Inflamm. Res., 48, 369–379 (1999).
Brouwers, J. R. and de Smet, P. A., Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.Clin. Pharmacokinet., 27, 462–485 (1994).
Buchanan, M. R., Endrenyi, L., Giles, A. R., and Rosenfeld, J., The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man.Thromb. Res. Suppl., 4, 145–152 (1983).
Buchsbaum, D. J., Zhou, T, and Lobuglio, A. F., TRAIL receptor-targeted therapy.Future Oncol., 2, 493–508 (2006).
Carvajal, A., Arias, L. H., Vega, E., Sanchez, J. A., Rodriguez, I. M., Ortega, P. G., and del Pozo, J. G., Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study.Eur. J. Clin. Pharmacol., 60, 439–444 (2004).
Chen, F., Sun, S., Kuhn, D. C., Gaydos, L. J., Shi, X., Lu, Y., and Demers, L. M., Involvement of NF-kappaB in silica-induced cyclooxygenase II gene expression in rat alveolar macrophages.Am. J. Physiol., 272, L779-L786 (1997).
Cho, J. Y, Baik, K. U., Jung, J. H., and Park, M. H., In vitro anti-inflammatory effects of cynaropicrin, a sesquiterpene lactone, fromSaussurea lappa.Eur. J. Pharmacol., 398, 399–407 (2000a).
Cho, J. Y., Baik, K. U., Yoo, E. S., Yoshikawa, K., and Park, M. H., In vitro antiinflammatory effects of neolignan woorenosides from the rhizomes ofCoptis japonica.J. Nat. Prod., 63, 1205–1209 (2000b).
Cho, J. Y., Chain, B. M., Vives, J., Horejsi, V., and Katz, D. R., Regulation of CD43-induced U937 homotypic aggregation.Exp. Cell Res., 290, 155–167 (2003a).
Cho, J. Y., Fox, D. A., Horejsi, V., Sagawa, K., Skubitz, K. M., Katz, D. R., and Chain, B., The functional interactions between CD98, beta1-integrins, and CD147 in the induction of U937 homotypic aggregation.Blood, 98, 374–382 (2001).
Cho, J. Y., Park, J., Yoo, E. S., Baik, K. U., Jung, J. H., Lee, J., and Park, M. H., Inhibitory effect of sesquiterpene lactones fromSaussurea lappa on tumor necrosis factor-alpha production in murine macrophage-like cells.Planta Med., 64, 594–597 (1998).
Cho, J. Y., Park, J. S., Baik, K. U., Lee, J. G, Kim, H. P., Yoo, E. S., and Park, M. H., Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevant to rheumatoid arthritis.Pharmacol. Res., 49, 423–431 (2004).
Cho, J. Y., Skubitz, K. M., Katz, D. R., and Chain, B. M., CD98-dependent homotypic aggregation is associated with translocation of protein kinase Cdelta and activation of mitogen-activated protein kinases.Exp. Cell Res., 286, 1–11 (2003b).
Cieslik, K., Zhu, Y., and Wu, K. K., Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway.J. Biol. Chem., 277, 49304–49310 (2002).
Dasgupta, J., Subbaram, S., Connor, K. M., Rodriguez, A. M., Tirosh, O., Beckman, J. S., Jourd’Heuil, D., and Melendez, J. A., Manganese superoxide dismutase protects from TNF-alpha-induced apoptosis by increasing the steady-state production of H2O2.Antioxid. Redox. Signal., 8, 1295–1305 (2006).
Devaux, Y., Seguin, C., Grosjean, S., de Talance, N., Camaeti, V., Burlet, A., Zannad, F., Meistelman, C., Mertes, P. M., and Longrois, D., Lipopolysaccharide-induced increase of prostaglandin E(2) is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase.J. Immunol., 167, 3962–3971 (2001).
Duperrier, K., Eljaafari, A., Dezutter-Dambuyant, C., Bardin, C., Jacquet, C., Yoneda, K., Schmitt, D., Gebuhrer, L., and Rigal, D., Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements.J. Immunol. Methods, 238, 119–131 (2000).
Grip, O., Janciauskiene, S., and Lindgren, S., Macrophages in inflammatory bowel disease.Curr. Drug Targets Inflamm. Allergy, 2, 155–160 (2003).
Guermonprez, P., Valladeau, J., Zitvogel, L., Thery, C., and Amigorena, S., Antigen presentation and T cell stimulation by dendritic cells.Annu. Rev. Immunol., 20, 621–667 (2002).
Hadjipavlou-Litina, D., Quantitative structure-activity relationship (QSAR) studies on non steroidal anti-inflammatory drugs (NSAIDs).Curr. Med. Chem., 7, 375–388 (2000).
Harizi, H. and Gualde, N., The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.Tissue Antigens, 65, 507–514 (2005).
Hovens, M. M., Snoep, J. D., Tamsma, J. T., and Huisman, M. V., Aspirin in the prevention and treatment of venous thromboembolism.J. Thromb. Haemost., 4, 1470–1475 (2006).
Huntjens, D. R., Danhof, M., and Delia Pasqua, O. E., Pharmacokinetic-pharmacodynamic correlations and bio-markers in the development of COX-2 inhibitors.Rheumatology (Oxford), 44, 846–859 (2005).
Jeon, Y J., Kim, Y K., Lee, M., Park, S. M., Han, S. B., and Kim, H. M., Radicicol suppresses expression of inducible nitric-oxide synthase by blocking p38 kinase and nuclear factor-kappaB/Rel in lipopolysaccharide-stimulated macrophages.J. Pharmacol. Exp. Ther., 294, 548–554 (2000).
Kassem, M. A. and Schulte, K. E., Influence of phenylbutazone, mofebutazone and aspirin on the pharmacokinetics of dexamethasone in the rat.Eur. J. Drug Metab. Pharmacokinet., 6, 11–20 (1981).
Katagiri, M., Ogasawara, T, Hoshi, K., Chikazu, D., Kimoto, A., Noguchi, M., Sasamata, M., Harada, S., Akama, H., Tazaki, H., Chung, U. I., Takato, T., Nakamura, K., and Kawaguchi, H., Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II.J. Bone Miner. Res., 21, 219–227 (2006).
Katerinaki, E., Haycock, J. W., Lalla, R., Carlson, K. E., Yang, Y., Hill, R. P., Lorigan, P. C., and MacNeil, S., Sodium salicylate inhibits TNF-alpha-induced NF-kappaB activation, cell migration, invasion and ICAM-1 expression in human melanoma cells.Melanoma Res., 16, 11–22 (2006).
Kinashi, T. and Katagiri, K., Regulation of immune cell adhesion and migration by regulator of adhesion and cell polarization enriched in lymphoid tissues.Immunology, 116, 164–171 (2005).
Knudsen, J. F., Carlsson, U., Hammarstrom, P., Sokol, G. H., and Cantilena, L. R., The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II.Inflammation, 28, 285–290 (2004).
Krieg, A. M., Direct immunologic activities of CpG DNA and implications for gene therapy.J. Gene Med., 1, 56–63 (1999).
Lebedeva, T., Dustin, M. L., and Sykulev, Y., ICAM-1 co-stimulates target cells to facilitate antigen presentation.Curr. Opin. Immunol., 17, 251–258 (2005).
Liu, J. F., Jamieson, G. G., Drew, P. A., Zhu, G. J., Zhang, S. W., Zhu, T. N., Shan, B. E., and Wang, Q. Z., Aspirin induces apoptosis in oesophageal cancer cells by inhibiting the pathway of NF-kappaB downstream regulation of cyclooxygenase-2.ANZJ. Surg., 75, 1011–1016 (2005).
Majai, G., Petrovski, G., and Fesus, L., Inflammation and the apopto-phagocytic system.Immunol. Lett., 104, 94–101 (2006).
McCarthy, D. M., Mechanisms of mucosal injury and healing: the role of non-steroidal anti-inflammatory drugs.Scand. J. Gastroenterol. Suppl., 208, 24–29 (1995).
Min, J. K., Kim, Y. M., Kim, S. W., Kwon, M. C., Kong, Y. Y., Hwang, I. K., Won, M. H., Rho, J., and Kwon, Y. G., TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells.J. Immunol., 175, 531–540 (2005).
Needs, C. J. and Brooks, P. M., Clinical pharmacokinetics of the salicylates.Clin. Pharmacokinet, 10, 164–177 (1985).
Owens, T., Babcock, A. A., Millward, J. M., and Toft-Hansen, H., Cytokine and chemokine inter-regulation in the inflamed or injured CNS.Brain Res. Brain Res. Rev., 48, 178–184 (2005).
Ozato, K., Tsujimura, H., and Tamura, T., Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.Biotechniques Suppl., 66–68, 70–72 (2002).
Park, Y. M., Won, J. H., Kim, Y H., Choi, J. W., Park, H. J., and Lee, K. T., In vivo and in vitro anti-inflammatory and anti-nociceptive effects of the methanol extract of Inonotus obliquus.J. Ethnopharmacol., 101, 120–128 (2005).
Raso, G. M., Pacilio, M., Di Carlo, G., Esposito, E., Pinto, L., and Meli, R., In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum.J. Pharm. Pharmacol., 54, 1379–1383 (2002).
Rose, D. M., The role of the alpha4 integrin-paxillin interaction in regulating leukocyte trafficking.Exp. Mol. Med., 38, 191–195 (2006).
Ruckemann, K., Fairbanks, L. D., Carrey, E. A., Hawrylowicz, C. M., Richards, D. F., Kirschbaum, B., and Simmonds, H. A., Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.J. Biol. Chem., 273, 21682–21691 (1998).
Schulz, M. and Schmoldt, A., Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.Pharmazie, 58, 447–474 (2003).
Steen, K. H., Steen, A. E., Kreysel, H. W., and Reeh, P. W., Inflammatory mediators potentiate pain induced by experimental tissue acidosis.Pain, 66, 163–170 (1996).
Subhashini, J., Mahipal, S. V, and Reddanna, P., Anti-proliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro.Cancer Lett., 224, 31–43 (2005).
Tamma, S. L., Sundaram, S. K., Lev, M., and Coico, R. F., Inhibition of sphingolipid synthesis down-modulates CD4 expression by peripheral blood T lymphocytes and T lymphoma cells.Biochem. Biophys. Res. Commun., 220, 916–921 (1996).
Toth, P. and Lazar, G., Brain phagocytes may empty tissue debris into capillaries.J Neurocytol., 30, 717–726 (2001).
Wu, K. K., Aspirin and other cyclooxygenase inhibitors: new therapeutic insights.Semin. Vasc. Med., 3, 107–112 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cho, J.Y. Immunomodulatory effect of nonsteroidal anti-inflammatory drugs (NSAIDs) at the clinically available doses. Arch Pharm Res 30, 64–74 (2007). https://doi.org/10.1007/BF02977780
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02977780